The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Correlation of circulating PD-L2 levels with outcomes of therapy with the anti-PD-1 antibody pembrolizumab (P) in patients (pts) with advanced soft tissue sarcomas (STS): Biomarker analysis of SARC028.
 
Melissa Amber Burgess
Travel, Accommodations, Expenses - Lilly
 
Jason Roszik
No Relationships to Disclose
 
Brian Andrew Van Tine
Consulting or Advisory Role - Advaxis; Caris Life Sciences; DFINE; EMD Serono; GlaxoSmithKline; Johnson & Johnson; Karyopharm Therapeutics; Lilly/ImClone; Novartis; Threshold Pharmaceuticals
Speakers' Bureau - Caris Life Sciences; DFINE; GlaxoSmithKline; Johnson & Johnson
Research Funding - Morphotek; Polaris
 
James Hu
Stock and Other Ownership Interests - Biogin
Consulting or Advisory Role - Amgen; Eisai; Merck Serono
Speakers' Bureau - Eisai
 
Scott Schuetze
Honoraria - EMD Serono; EMD Serono; Janssen Research & Development
Consulting or Advisory Role - EMD Serono; EMD Serono; Janssen Research & Development
Research Funding - AB Science (Inst); Amgen (Inst); BioMed Valley Discoveries (Inst); CytRx Corporation (Inst); Janssen Research & Development (Inst); Lilly (Inst); Plexxikon (Inst); Threshold Pharmaceuticals (Inst); ZIOPHARM Oncology (Inst)
 
Sandra P. D'Angelo
Consulting or Advisory Role - Amgen; EMD Serono
 
Steven Attia
Consulting or Advisory Role - EMD Serono; Gradalis; Karyopharm Therapeutics
Research Funding - AB Science (Inst); Bayer (Inst); CytRx Corporation (Inst); Daiichi Sankyo (Inst); Morphotek (Inst); Novartis (Inst); Threshold Pharmaceuticals (Inst); TRACON Pharma (Inst); ZIOPHARM Oncology (Inst)
 
Dennis A. Priebat
No Relationships to Disclose
 
Scott H. Okuno
Consulting or Advisory Role - EMD Serono
 
Richard F. Riedel
Employment - Biotech Prosthetic Orthotics of North Carolina (I); Limbguard (I)
Leadership - Biotech Prosthetic Orthotics of North Carolina (I); Limbguard (I)
Stock and Other Ownership Interests - Biotech Prosthetic Orthotics of North Carolina (I); Limbguard (I)
Honoraria - Novartis
Consulting or Advisory Role - CytRx Corporation; Eisai; GlaxoSmithKline; Lilly; Merck; Morphotek; Novartis
Research Funding - AADi (Inst); Agios (Inst); Arog (Inst); Astex Pharmaceuticals (Inst); Bayer (Inst); Eisai (Inst); Immune Design (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Plexxikon (Inst); Threshold Pharmaceuticals (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - PandoNet - Limbguard (I)
Travel, Accommodations, Expenses - EMD Serono; Janssen; Novartis
 
Lara Emily Davis
No Relationships to Disclose
 
Sujana Movva
No Relationships to Disclose
 
Damon R. Reed
Consulting or Advisory Role - EMD Serono
 
Laurence H. Baker
Consulting or Advisory Role - Morphotek; Teva
 
Denise K. Reinke
Research Funding - Bayer (Inst); Tesaro (Inst); Threshold Pharmaceuticals (Inst)
 
Robert G. Maki
Stock and Other Ownership Interests - Gilead Sciences
Consulting or Advisory Role - Arcus Ventures; Bayer; Eisai; Gem Pharmaceuticals; Immune Design; Lilly/ImClone; Presage Biosciences; SARC: Sarcoma Alliance for Research though Collaboration; TRACON Pharma
Research Funding - Immune Design (Inst); Lilly (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Uptodate: I write and edit chapters for their online text book.
Travel, Accommodations, Expenses - Bayer/Onyx; Janssen Oncology; TRACON Pharma
 
Shreyaskumar Patel
Consulting or Advisory Role - CytRx Corporation; Daiichi Sankyo; EMD Serono; Johnson & Johnson; Novartis
Research Funding - Eisai (Inst); Johnson & Johnson (Inst); Morphotek (Inst); PharmaMar (Inst)
 
Hussein Abdul-Hassan Tawbi
Consulting or Advisory Role - Novartis
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst); Novartis (Inst)
 
Lisa Helene Butterfield
Stock and Other Ownership Interests - Kite, a Gilead company
Consulting or Advisory Role - Affymetrix; AstraZeneca; Biodesix; Caladrius Biosciences; Merck; Oxford Immunotec; Verastem
Patents, Royalties, Other Intellectual Property - Alpha Fetoprotein as an antigen for T cell responses in hepatocellular cancer